Mustang Bio Inc (MBIO) Cumulative Dividend Pay out History TTM by Quarter, Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
• Dividend Growth
• Cumulative Pay out
Mustang Bio inc   (NASDAQ: MBIO)

 

MBIO's Dividend Pay out ratio over the 12 Months Period

Cumulative by Quarter, Trailing twelve months

Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.



According to the latest data Jun 30 2026, it is not possible to calculate dividend pay out ratio.
Visit Mustang Bio Inc Cash flow


Dividend in Glossary



Back to MBIO Dividend Comparisons >> See also MBIO's dividend growth by quarter >> See also MBIO's eps growth
Cumulative Dividend Pay out Ratio II. Quarter
(Jun 30 2026)		 I. Quarter
(Mar 31 2026)		 IV. Quarter
(Dec 31 2025)		 III. Quarter
(Sep 30 2025)		 II. Quarter
(Jun 30 2025)
MBIO's Pay out Ratio (TTM) - - - - -
MBIO's Dividend Pay out Ratio Total Ranking # # # # #

  News about Mustang Bio inc Dividends

Catchy Mustang Bio, Inc. Gallops Ahead with Groundbreaking Funding for Cancer Cell Therapies

Mustang Bio, Inc. Announces Registered Direct Offering and Private Placement to Advance Cell Therapies for Cancer Treatment
Worcester, Mass. ?? June 20, 2024 ?? Mustang Bio, Inc. (Nasdaq: MBIO) has recently made significant strides in the field of biopharmaceuticals with the announcement of a definitive agreement for the issuance and sale of 6,130,000 shares of its common stock in a registered direct offering priced at $0.41 per share. This offering, conducted under Nasdaq rules, represents a crucial step in Mustang’s mission to translate cutting-edge medical breakthroughs in cell therapies into potential cures for challenging-to-treat cancers.
In addition to the registered direct offering, Mustang has also engaged in a concurrent private placement, where the company will issue and sell unregistered warrants to purchase up to 6,130,000 shares of its common stock. This strategic move is aimed at bolstering Mustang’s research and development efforts in the field of oncology, furthering their commitment to revolutionizing cancer treatment through innovative cell therapies.

MBIO's Dividend Pay out Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
S&P 500 #

Dividend Pay out Ratio Statistics
High Average Low
0 % 0 % 0 %
 



Other Dividend Ratios
Highest Ranking Dividend Yield
Lowest Ranking Dividend Yield
Annual Dividend Pay out for MBIO
MBIO's Dividend Yield




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.